{"filings":[{"id":1895279,"accession_number":"0001628280-26-049923","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-07-28T11:03:16+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 revenue $4.37B up 8.7% YoY, adj EPS $3.15 up 12.1%, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $256M, GAAP diluted EPS $1.53; adjusted EBITDA $994M (+9.2% YoY).","R&D Solutions net new bookings $3.15B (+19% YoY), book-to-bill 1.22x; backlog $34.2B.","Raising FY 2026 guidance: revenue $17,275-17,475M, adj EBITDA $4,000-4,050M, adj EPS $12.80-13.00.","Q2 free cash flow $360M (+23.3% YoY); repurchased $398M of stock in Q2, $950M in H1.","Commercial Solutions revenue $1,793M (+8.6% YoY); R&D Solutions revenue $2,575M (+8.8% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1001597,"accession_number":"0001193125-26-267763","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-06-11T20:46:50+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA issues €950M 4.625% senior notes due 2033 to refinance debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Gross proceeds of €950M from 4.625% senior notes due June 15, 2033; interest payable semi-annually.","Net proceeds to refinance existing indebtedness and pay offering fees and expenses.","Notes are unsecured obligations of IQVIA Inc., guaranteed by certain subsidiaries.","Issuer may redeem notes before June 15, 2029 with make-whole premium; thereafter declining premium from 2.313% to 0%.","Interest begins December 15, 2026; maturity June 15, 2033 unless earlier redeemed or repurchased."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":863237,"accession_number":"0001193125-26-257730","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-06-04T21:08:13+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA Inc. prices €950M senior notes due 2033 at 4.625% for debt refinancing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Subsidiary IQVIA Inc. priced €950M aggregate principal amount of senior notes due 2033.","Notes bear interest at 4.625% per annum, payable semi-annually beginning Dec 15, 2026.","Proceeds to refinance existing indebtedness and pay fees/expenses related to the offering.","Closing expected on or about June 11, 2026, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":835158,"accession_number":"0001193125-26-255635","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-06-03T20:45:12+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA subsidiary to issue €950M senior notes due 2033 to refinance debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc. intends to raise €950,000,000 through a private offering of senior notes due 2033.","Proceeds will refinance certain existing indebtedness and pay offering fees and expenses.","Offering is subject to market and customary conditions; not yet closed.","Notes sold only to QIBs in the U.S. under Rule 144A and to non-U.S. investors under Regulation S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93088,"accession_number":"0001193125-26-212463","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA board authorizes additional $2B share repurchase; total authorization reaches $3.2B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved $2B increase to existing repurchase program, bringing total remaining authorization to $3.217B.","Repurchases may be made in open market, block trades, or privately; no expiration date set.","Management will determine timing and amount based on stock price, corporate requirements, and market conditions.","Program can be modified, suspended, or discontinued at any time without notice.","Company may also repurchase shares outside the program via private transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93087,"accession_number":"0001628280-26-030118","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $4.15B (+8.4% YoY); adj. EPS $2.90; raises FY2026 adj. EPS guidance to $12.65-12.95","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $274M ($1.61 EPS); Adjusted EBITDA $932M (+5.5% YoY).","Commercial Solutions revenue $1,754M (+11.6% reported); R&D Solutions $2,397M (+6.2%).","R&D Solutions backlog $34.2B; net new bookings $2.5B; book-to-bill 1.04x.","Free cash flow $491M (+15% YoY); repurchased $552M of common stock in Q1.","FY2026 revenue reaffirmed $17.15-17.35B; adj. EPS guidance raised to $12.65-12.95."],"consensus_eps_estimate":null,"consensus_eps_actual":1.61,"consensus_revenue_estimate":null,"consensus_revenue_actual":4151000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93086,"accession_number":"0001193125-26-173771","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-04-23T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"IQVIA stockholders approve 2026 equity plan and re-elect directors at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 9 director nominees elected with over 79% votes cast in favor; Ari Bousbib received 138.4M for, 8.6M against.","Advisory say-on-pay passed with ~80% support (118.4M for, 29.4M against).","PricewaterhouseCoopers ratified as auditor for 2026 with 140.9M votes for (90.8% of votes cast).","2026 Incentive and Stock Award Plan approved with ~65% of votes cast in favor (97.0M for, 51.0M against); reserves 17.94M shares.","Stockholder proposal to split Chairman and CEO roles rejected with 36.7M for (24.8% of votes cast)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104417,"accession_number":"0001628280-26-005605","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q4 revenue up 10.3% to $4.36B; adj EPS $3.42, issues FY2026 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $4,364M (+10.3% YoY); GAAP EPS $2.99, adj. EPS $3.42 (+9.6% YoY).","R&D Solutions Q4 bookings $2.7B (book-to-bill 1.18x); backlog $32.7B (+5.3% YoY).","Full-year 2026 guidance: revenue $17.15-17.35B, adj. EBITDA $3.975-4.025B, adj. EPS $12.55-12.85.","Segment reorg effective Jan 1, 2026: CSMS folded into TAS (renamed Commercial Solutions); some real-world offerings moved to R&DS.","Q4 share repurchases $212M; full-year $1,244M; $1.769B authorization remaining."],"consensus_eps_estimate":null,"consensus_eps_actual":7.84,"consensus_revenue_estimate":null,"consensus_revenue_actual":16310000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120708,"accession_number":"0001193125-25-312900","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA refinances $2.19B term loans and $2B revolver, cuts USD interest rate, releases Swiss/Japan borrowers","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2.19B Term A Dollar Loans and $2B Revolving Credit Commitments on December 9, 2025.","Interest rate on USD term loans and revolving loans reduced by eliminating term SOFR credit spread adjustment.","Swiss Subsidiary Borrower and Japanese Borrower released from all obligations; related collateral documents terminated.","Existing €250M Term A Euro Loans refinanced into new euro term loans.","BofA Securities, PNC, JPMorgan, MUFG, TD Securities, Truist, Wells Fargo, HSBC, Citi, Barclays, Goldman Sachs as lead arrangers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120707,"accession_number":"0001193125-25-267053","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Nobel laureate Dr. William G. Kaelin Jr. appointed to IQVIA board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment effective November 5, 2025.","Kaelin awarded 2019 Nobel Prize in Physiology or Medicine for oxygen-sensing and VHL tumor suppressor work.","Senior physician-scientist at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School.","Also serves on Eli Lilly board and chairs its Science and Technology Committee.","Board determined Kaelin meets NYSE independence standards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120706,"accession_number":"0001628280-25-046554","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue up 5.2% to $4.1B, adj EPS $3.00; reaffirms FY guide","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4,100M (+5.2% YoY); GAAP EPS $1.93, adj EPS $3.00.","R&D Solutions bookings $2.6B (book-to-bill 1.15x); backlog $32.4B (+4.1% YoY).","Operating cash flow $908M; free cash flow $772M (+35% YoY).","FY2025 guide reaffirmed: rev $16.15-16.25B, adj EBITDA $3.775-3.8B, adj EPS $11.85-11.95.","TAS rev $1,631M (+5.0%), R&DS $2,260M (+4.5%), CSMS $209M (+16.1%)."],"consensus_eps_estimate":null,"consensus_eps_actual":4.86,"consensus_revenue_estimate":null,"consensus_revenue_actual":11946000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137300,"accession_number":"0001193125-25-193510","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"IQVIA appoints Michael Fedock as CFO; Ron Bruehlman to retire Feb 28, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Fedock, currently SVP of FP&A, becomes EVP and CFO effective February 28, 2026.","Ron Bruehlman retires as CFO and transitions to Senior Advisor to the CEO.","Fedock's base salary rises to $750,000 with annual cash incentive target of 100% of base salary; eligible for LTI grants.","Fedock has over 25 years in healthcare, including CFO roles at IQVIA Laboratories and R&D Solutions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137299,"accession_number":"0001478242-25-000102","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 revenue $4.017B (+5.3% YoY); adj. EPS $2.81; updates FY25 guidance to $11.75-$12.05","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $4,017M (+5.3% YoY); GAAP net income $266M ($1.54 diluted EPS); adjusted diluted EPS $2.81.","R&D Solutions backlog $32.1B (+5.1% YoY); Q2 bookings $2.5B (book-to-bill 1.12x); TAS revenue $1,628M (+8.9% YoY).","Repurchased $607M of stock in Q2 ($1.03B year-to-date); $1.98B authorization remaining.","Updates FY25 guidance: revenue $16.1B-$16.3B, adj. EBITDA $3.75B-$3.825B, adj. diluted EPS $11.75-$12.05.","Net leverage 3.61x; operating cash flow $443M; free cash flow $292M."],"consensus_eps_estimate":null,"consensus_eps_actual":2.94,"consensus_revenue_estimate":null,"consensus_revenue_actual":7846000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154614,"accession_number":"0001193125-25-134940","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-06-04T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA issues $2B of 6.250% senior notes due 2032 to repay revolver borrowings","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc., wholly owned subsidiary, issued $2B of 6.250% senior notes due June 1, 2032.","Net proceeds to repay existing revolving credit facility borrowings, pay fees, and for general corporate purposes.","Interest payable semi-annually on June 1 and December 1, starting December 1, 2025.","Notes redeemable at make-whole prior to June 1, 2028, then at declining premium from 3.125% to 0.000%.","Notes are unsecured obligations, guaranteed by certain subsidiaries of IQVIA Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154613,"accession_number":"0001193125-25-133449","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-06-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA subsidiary prices $2B senior notes at 6.250% due 2032, proceeds to repay revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc. issues $2,000,000,000 in senior notes due 2032 bearing 6.250% annual interest.","Proceeds will repay existing revolving credit facility borrowings and cover fees and expenses.","Notes mature June 1, 2032; interest paid semi-annually on June 1 and December 1, starting Dec 1, 2025.","Closing expected on or about June 4, 2025, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154612,"accession_number":"0001478242-25-000082","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $3,829M, adjusted EPS $2.70 (+6.3%); raises FY revenue guidance on FX","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $249M ($1.40 EPS); adjusted EBITDA $883M (+2.4% YoY).","R&D Solutions backlog $31.5B (+4.8% YoY); quarterly book-to-bill 1.02x, TTM book-to-bill 1.14x.","TAS revenue $1,546M (+6.4% reported, +7.6% constant currency); CSMS revenue $181M (-4.2%).","Operating cash flow $568M, free cash flow $426M (+13% YoY); repurchased $425M of stock.","FY 2025 revenue guidance raised $275M to $16.0-16.4B on FX; profit guidance reaffirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":1.4,"consensus_revenue_estimate":null,"consensus_revenue_actual":3829000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154611,"accession_number":"0001193125-25-093687","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-04-24T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"IQVIA stockholders approve charter amendment for officer exculpation, elect directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders approved amendment to certificate of incorporation to exculpate officers to fullest extent under Delaware law and remove classified board provisions.","All nine director nominees elected with majority support; Todd B. Sisitsky received 131.7M for, 20.6M against.","Advisory vote on 2024 executive compensation passed with 125.6M for, 26.2M against.","Stockholder proposal on special meetings failed with 66.2M for, 86.0M against.","PricewaterhouseCoopers ratified as independent auditor for 2025 with 145.6M for, 14.7M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173143,"accession_number":"0001193125-25-050927","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA refinances $1.985B term loans, cuts B-4 rate 25 bps, repays Euro loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$1.985B new Term B-5 Dollar Loans issued to refinance Term B-4 Dollar Loans and repay Term B-2 Euro Loans.","Interest rate on Term B-4 Dollar Loans reduced from SOFR+2.00% to SOFR+1.75% per annum.","JPMorgan Chase provided additional incremental Term B-5 commitment of ~$680.7M.","Amendment effective March 10, 2025; proceeds also used for general corporate purposes and fees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173142,"accession_number":"0001478242-25-000016","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q4 adj EPS $3.12 (+9.9% YoY), backlog $31.1B; reaffirms FY25 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3,958M (+3.0% cc), GAAP EPS $2.42, adj EPS $3.12; FY revenue $15,405M.","FY adjusted EPS $11.13 (+9.1%), free cash flow $2,114M (+41%), operating cash flow $2,716M (+26%).","R&D Solutions backlog $31.1B (+5.5% cc), Q4 book-to-bill 1.20x; TAS revenue +9.5% cc.","Board added $2B to buyback authorization, total remaining $3.013B; $1.35B repurchased in 2024.","Reaffirms FY2025 guidance: revenue $15.725B-$16.125B, adj EBITDA $3.765B-$3.885B, adj EPS $11.70-$12.10."],"consensus_eps_estimate":null,"consensus_eps_actual":7.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":15405000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190168,"accession_number":"0001478242-24-000113","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue $3,896M, Adj EPS $2.84 (+14.1%); FY24 guidance cut on trial delays","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $3,896M (+4.3% YoY); GAAP EPS $1.55; Adj EPS $2.84 (+14.1%).","R&D Solutions backlog $31.1B (+8% YoY); book-to-bill 1.22x TTM (excl. cancellation).","TAS revenue $1,554M (+8.6% YoY), accelerating from prior quarters.","FY24 guidance lowered: rev $15,350-15,400M; Adj EPS $11.10-11.20 due to two mega trial delays.","Operating cash flow YTD $1,831M (+31% YoY); FCF $1,393M (+49% YoY); $200M share buyback in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":5.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":11447000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206676,"accession_number":"0001478242-24-000090","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-07-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 2024 revenue $3.81B (+2.3% YoY), adj EPS $2.64, updated FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,814M (+2.3% reported, +3.5% constant currency); GAAP net income $363M, diluted EPS $1.97.","Adjusted diluted EPS $2.64 (+8.6% YoY); Adjusted EBITDA $887M (+2.7% YoY).","R&D Solutions bookings $2.7B (book-to-bill 1.27x); backlog $30.6B (+7.7% YoY).","Full-year 2024 guidance: revenue $15,425M-$15,525M, Adj EBITDA $3,705M-$3,765M, Adj EPS $11.10-$11.30.","Q2 free cash flow $445M; net leverage ratio 3.25x trailing twelve-month Adj EBITDA."],"consensus_eps_estimate":null,"consensus_eps_actual":3.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":7551000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223868,"accession_number":"0001193125-24-136226","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"IQVIA President Kevin Knightly transitions to Senior Advisor to CEO effective May 15","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kevin C. Knightly steps down as President, Corporate Strategy and Enterprise Networks effective May 15, 2024.","He will become Senior Advisor to CEO; compensation commensurate with the new role.","No successor announced; transition is a planned role change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223867,"accession_number":"0001193125-24-128463","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $3,737M, adj EPS $2.54; reaffirms FY guidance with FX adjustment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $1.56; adjusted EPS $2.54; adjusted EBITDA $862M (+1.3% YoY).","R&DS backlog $30.1B (+7.9% YoY); Q1 book-to-bill 1.23x (over 1.3x excl. large CNS cancellation).","Revenue +2.3% reported (+2.9% CC); TAS +0.6%, R&DS +3.4%, CSMS +3.8%.","FY 2024 revenue guidance lowered $75M for FX to $15,325M-$15,575M; adj EBITDA ($3.7B-$3.8B) and adj EPS ($10.95-$11.25) reaffirmed.","Operating cash flow $522M; free cash flow $377M; net leverage 3.38x."],"consensus_eps_estimate":null,"consensus_eps_actual":1.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":3737000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223866,"accession_number":"0001193125-24-098516","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-04-17T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"IQVIA stockholders elect all six director nominees, approve say-on-pay at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected all six director nominees; Sheila Stamps received 159.7M votes for, Todd Sisitsky 129.9M.","Advisory say-on-pay approved with 134.1M for, 26.1M against, 379K abstain.","Stockholder proposal on political spending rejected: 21.1M for, 138.0M against.","Ratification of PwC as auditor for 2024 passed with 152.2M for, 14.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243256,"accession_number":"0001157523-24-000236","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA reports Q4 revenue $3.87B, GAAP EPS $2.54; issues FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3,868M (+3.5% YoY); GAAP net income $469M (+106.6%); adjusted EPS $2.84 (+2.2%).","Full-year 2023 revenue $14,984M (+4.0%); adjusted EBITDA $3,569M (+6.7%); adjusted diluted EPS $10.20.","R&D Solutions contracted backlog $29.7B (+9.2% YoY); Q4 book-to-bill 1.31x.","FY2024 guidance: revenue $15.4-15.65B, adjusted EBITDA $3.7-3.8B, adjusted EPS $10.95-$11.25.","Refinanced $2.75B debt to 2029/2031 at ~4.9% fixed; over 80% debt fixed. Q4 share repurchases $229M."],"consensus_eps_estimate":null,"consensus_eps_actual":7.29,"consensus_revenue_estimate":null,"consensus_revenue_actual":14984000000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260656,"accession_number":"0001193125-23-284299","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-11-28T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"IQVIA issues $1.25B 6.250% senior secured notes due 2029 and $1.5B incremental term loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1.25B of 6.250% senior secured notes maturing February 1, 2029; interest payable semiannually.","Borrowed $1.5B of incremental Term B-4 Dollar Loans under its existing credit agreement on November 28, 2023.","Proceeds together with the notes will repay Euro-denominated TLB due 2024 and USD-denominated TLBs due 2025.","Entered cross-currency swaps to convert notes and loans into euro borrowings at effective rates of 4.8555% and 4.9015%.","Notes redeemable prior to January 1, 2029 with make-whole premium; thereafter at par plus accrued interest."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260655,"accession_number":"0001193125-23-277584","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-11-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA upsizes senior notes offering to $1.25B at 6.250% due 2029; refinances near-term debt","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc. priced $1.25B senior secured notes at 6.250%, due Feb 2029; upsized from initial $500M on strong demand.","Proceeds will repay existing term loans due 2024/2025 and pay fees; closing expected Nov 28, 2023.","Concurrently, IQVIA Inc. intends a new $1.25B Term Loan B due 2031 under credit facility amendment.","Cross-currency swap converts $1.25B notes to euro borrowing; effective net rate ~4.8555%.","Notes unregistered, offered under Rule 144A/Reg S; customary closing conditions apply."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":260654,"accession_number":"0001157523-23-001589","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-11-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue $3.736B (+4.9%), adjusted EPS $2.49; FY23 guidance revised to $14.885-$14.92B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,736M (+4.9%), GAAP net income $303M (+7.1%), adjusted EBITDA $888M (+9.1%).","R&D Solutions bookings $2.6B (book-to-bill 1.24x); backlog $28.8B (+11.7% YoY).","Full-year 2023 guidance: revenue $14,885-$14,920M; adj. EBITDA $3,560-$3,570M; adj. EPS $10.16-$10.23.","Q3 operating cash flow $583M, free cash flow $437M; repurchased $144M in shares, $2.6B authorization remains."],"consensus_eps_estimate":null,"consensus_eps_actual":4.76,"consensus_revenue_estimate":null,"consensus_revenue_actual":11116000000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277937,"accession_number":"0001193125-23-242586","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-09-26T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"IQVIA appoints Richard Staub III as President of R&DS, replacing retiring Costa Panagos","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Richard Staub III appointed President of Research & Development Solutions effective September 25, 2023.","Costa Panagos retired after 24-year career at IQVIA; his last day was September 25, 2023.","Staub previously served as R&DS President from 2016 to 2022 and was senior advisor to the Chairman and CEO.","Staub brings 34 years of life science industry experience to the role."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":277936,"accession_number":"0001157523-23-001201","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 revenue $3.73B (+5.3% YoY), GAAP EPS $1.59 (+18.7%), Adj EPS $2.43 (-0.4%); R&D backlog $28.4B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,728M, up 5.3% reported and 5.5% constant currency; R&D Solutions revenue $2,096M (+7.5%).","GAAP net income $297M (+16% YoY); Adjusted EBITDA $864M (+8.0%); Adj. diluted EPS $2.43 (down 0.4%).","R&D Solutions bookings $2.7B (book-to-bill 1.28x); contracted backlog $28.4B (+11% YoY).","Full-year 2023 guidance: revenue $15,050M-$15,175M, Adj. EBITDA $3,600M-$3,635M, Adj. EPS $10.20-$10.45.","Board increased share repurchase authorization by $2B to $2,736M remaining; $490M repurchased in Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":3.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":7380000000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295962,"accession_number":"0001193125-23-151851","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-05-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA subsidiary issues $1.25B in senior secured and senior notes to repay revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $750M 5.700% senior secured notes due 2028 and $500M 6.500% senior notes due 2030.","Net proceeds to repay existing borrowings under revolving credit facility and pay offering fees/expenses.","Senior Secured Notes mature May 15, 2028; Senior Notes mature May 15, 2030; interest semi-annual.","Notes are guaranteed by IQVIA Holdings and certain subsidiaries; secured notes are secured obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295961,"accession_number":"0001193125-23-148426","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-05-19T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"IQVIA subsidiary prices $1.25B notes offering to refinance credit facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["IQVIA Inc. priced $750M senior secured notes due 2028 at 5.700% and $500M senior notes due 2030 at 6.500%.","Total offering upsized from $1B to $1.25B due to strong demand.","Proceeds to repay existing borrowings under IQVIA Inc.'s revolving credit facility and pay related fees.","Issuance expected to close May 23, 2023, subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295960,"accession_number":"0001157523-23-000632","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-04-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 revenue $3.65B, adjusted EPS $2.45; reaffirms FY2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,652M, up 2.4% reported (4.7% constant currency) vs Q1 2022.","GAAP diluted EPS $1.53; adjusted diluted EPS $2.45; adjusted EBITDA $851M.","R&D Solutions backlog $27.9B (+10.1% YoY); book-to-bill 1.28x; bookings $2.6B.","FY2023 guidance reaffirmed: revenue $15.15-15.4B, adjusted EPS $10.26-10.56.","Q1 operating cash flow $417M; free cash flow $253M; $129M in share repurchases."],"consensus_eps_estimate":null,"consensus_eps_actual":1.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":3652000000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295959,"accession_number":"0001478242-23-000055","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-04-18T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA amends credit facility, ups revolver to $2.0B, transitions to SOFR","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Revolving credit commitments increased to $2.0 billion under Fifth Amended Credit Agreement.","Benchmark rate for revolver and portion of term loans replaced LIBOR with SOFR.","Amendment effective April 17, 2023; Bank of America serves as administrative agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":295958,"accession_number":"0001140361-23-018951","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-04-18T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"IQVIA stockholders approve special meeting right for 25% holders; charter/bylaws amended","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved charter amendment granting stockholders holding ≥25% of outstanding common stock the right to request a special meeting.","Amendment and corresponding bylaw amendments became effective upon filing with Delaware Secretary of State on April 18, 2023.","Three directors elected: Carol J. Burt, Colleen A. Goggins, Sheila A. Stamps, each with majority support.","Advisory say-on-pay proposal passed with 126.7M for (74.4%) vs 32.5M against.","PricewaterhouseCoopers LLP ratified as independent auditor for FY2023 with 155.1M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316498,"accession_number":"0001478242-23-000025","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-02-13T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"IQVIA amends bylaws to adopt majority voting standard for director elections","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board adopted majority voting in uncontested director elections, aligned with ~99% of S&P 500.","Advance notice provisions updated to comply with SEC universal proxy rules.","Amendments reflect recent Delaware General Corporation Law changes regarding stockholder meetings.","Technical and conforming revisions also included; effective February 13, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":316497,"accession_number":"0001157523-23-000245","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2023-02-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q4 2022 adj EPS $2.78 (+9% YoY); FY 2023 guidance adj EPS $10.26-$10.56","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $3,739M (+2.8% reported, +7.0% CC); full-year revenue $14,410M (+3.9% reported).","Q4 GAAP diluted EPS $1.20 (down 26.4% YoY); adjusted diluted EPS $2.78 (up 9.0% YoY).","R&D Solutions book-to-bill 1.51x; contracted backlog of $27.2B, up 9.6% YoY.","FY 2023 guidance: revenue $15,150M-$15,400M; adj EBITDA $3,625M-$3,695M.","Adjusted diluted EPS guidance of $10.26-$10.56 includes ~10pp hit from higher interest/UK tax."],"consensus_eps_estimate":null,"consensus_eps_actual":5.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":14410000000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334767,"accession_number":"0001157523-22-001388","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue $3.56B +5% reported, +10.5% CC; adj EPS $2.48 +14.3% YoY; raises FY adj EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,562M, +5.0% reported / +10.5% constant currency; GAAP EPS $1.49, Adj EPS $2.48 (both up ~11-14% YoY).","R&D Solutions quarterly bookings over $2.5B; services book-to-bill 1.39x; backlog $25.8B +5.4% YoY.","Full-year 2022 revenue guidance narrowed to $14,325-$14,425M, Adj EBITDA $3,330-$3,360M; Adj EPS raised to $10.10-$10.20.","Free cash flow $698M in Q3, $1,197M YTD; repurchased $150M in Q3 ($1.14B YTD); remaining authorization $1.38B.","Q4 guidance: revenue $3,654-$3,754M, Adj EBITDA $904-$934M, Adj EPS $2.72-$2.82."],"consensus_eps_estimate":null,"consensus_eps_actual":4.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":10671000000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":334766,"accession_number":"0001478242-22-000095","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-10-03T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ronald A. Rittenmeyer resigns from IQVIA board and LDCC chair due to health reasons","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Rittenmeyer resigned effective October 2, 2022, citing personal health reasons.","He served as board member and chairman of the Leadership Development and Compensation Committee.","Resignation was not due to any disagreement with the company on operations, policies, or practices.","No replacement named for the board seat or LDCC chair as of the filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352186,"accession_number":"0001478242-22-000087","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-07-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"IQVIA appoints Keriann Cherofsky as Principal Accounting Officer, SVP Corporate Controller","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Keriann Cherofsky appointed SVP Corporate Controller and principal accounting officer, effective Aug 1, 2022.","Compensation: $335k base salary, 50% annual incentive target, $285k long-term equity award.","Emmanuel Korakis to depart July 31, 2022 to become CFO of Presidio, Inc."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352185,"accession_number":"0001157523-22-000882","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-07-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 revenue $3.54B +7.1% constant currency; adj EPS $2.44 +14.6% YoY; FY guidance updated for FX","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $3,541M (+3.0% reported, +7.1% constant currency); GAAP diluted EPS $1.34 (+48.9%); adj diluted EPS $2.44 (+14.6%).","Adjusted EBITDA $800M (+10.8% YoY).","R&D Solutions quarterly bookings over $2.6B; contracted backlog $25.6B (+7.1% YoY).","Share repurchase $590M in Q2, $993M YTD; $1.53B remaining authorization.","FY 2022 revenue guidance revised to $14.4B–$14.55B (for FX); reaffirmed Adj EBITDA $3,345M–$3,395M and Adj EPS $10.00–$10.20."],"consensus_eps_estimate":null,"consensus_eps_actual":3.02,"consensus_revenue_estimate":null,"consensus_revenue_actual":7109000000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":369698,"accession_number":"0001193125-22-175628","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-06-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA borrows $1.25B in incremental Term A Loans; repays $950M of revolver","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Borrowed $1.25B in incremental Term A-2 Dollar Loans on June 16, 2022.","Proceeds used to repay ~$950M of outstanding revolving credit loans and for general corporate purposes.","Upfront fee of 0.25% paid to JPMorgan for ratable account of new lenders.","Amendment involves 16 lenders including JPMorgan, Bank of America, PNC, HSBC, Wells Fargo, TD."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":369697,"accession_number":"0001157523-22-000479","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-04-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q1 adj. EPS $2.47 (+13.3%), revenue $3.57B (+4.7%); lowers FY revenue guidance on FX and Ukraine","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $325M (+53.3%), GAAP diluted EPS $1.68 (+54.1%); adjusted EBITDA $812M (+9.1%).","Record R&D Solutions services bookings over $1.9B; backlog $25.3B, up 9.1% YoY; $7.0B expected to convert in next 12 months.","FY revenue guidance revised to $14.45B-$14.75B (4.2-6.3% reported) due to dollar strength and Ukraine/Russia disruption; adj. EBITDA and EPS reaffirmed.","Q2 guidance: revenue $3.47B-$3.52B; adj. EBITDA $790M-$805M; adj. EPS $2.35-$2.42, representing 10-14% growth.","Repurchased $403M of stock in Q1; $2.12B remaining authorization; net leverage 3.6x."],"consensus_eps_estimate":null,"consensus_eps_actual":1.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":3568000000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":369696,"accession_number":"0001478242-22-000057","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-04-14T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"IQVIA stockholders approve board declassification; annual election of all directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Proposal to declassify board approved with 158.8M for vs 0.3M against; charter and bylaws amended effective April 12, 2022.","Four Class III directors elected: Connaughton, Danhakl, Fasano, Morris; each received >147M votes for.","Advisory say-on-pay vote: 119.8M for (75.5%) vs 37.8M against; non-binding.","Shareholder proposal on majority voting received 93.3M for (58.6%) vs 65.8M against; not adopted.","Ratification of PwC as auditor for FY2022: 159.5M for, 5.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":388827,"accession_number":"0001478242-22-000045","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-03-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"IQVIA appoints Costa Panagos as President of R&DS, succeeding retiring Richard Staub III","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Costa Panagos named President of Research & Development Solutions effective April 1, 2022.","Panagos has 25+ years experience; previously President of R&D Operations and CEO of Q2 Solutions.","Richard Staub III retires as President R&DS but remains Senior Advisor to the CEO for business development.","Staub's transition follows a long-planned succession; he will serve on customer governance boards.","Appointment is an internal promotion; Panagos joined IQVIA (then Quintiles) in 1999."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":388826,"accession_number":"0001157523-22-000202","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-02-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q4 revenue $3.6B (+10.2%), raises FY22 profit guidance; backlog record $24.8B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS $1.63 (+167% YoY); Adjusted diluted EPS $2.55 (+20.9%); Revenue $3,636M (+10.2% reported).","Full-year 2021: Revenue $13,874M (+22.1%); Adjusted EBITDA $3,022M (+26.8%); record free cash flow $2,302M.","R&D Solutions contracted backlog record $24.8B (+10.2%); book-to-bill 1.36x (excl. pass-throughs).","FY2022 guidance: Revenue $14.7B-$15.0B reaffirmed despite $70M FX headwind; Adjusted EBITDA raised to $3.33B-$3.405B.","Share repurchase authorization increased by $2.0B in Feb 2022, bringing total remaining to ~$2.5B."],"consensus_eps_estimate":null,"consensus_eps_actual":4.95,"consensus_revenue_estimate":null,"consensus_revenue_actual":13874000000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":388825,"accession_number":"0001193125-22-018468","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2022-01-27T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"IQVIA appoints Leslie Wims Morris and Sheila A. Stamps to board of directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Leslie Wims Morris appointed Jan 24, 2022; Managing Director & Head of Corp Dev, JPMorgan Chase Consumer & Community Banking.","Sheila A. Stamps appointed Jan 26, 2022; former senior investment advisor to NY Comptroller, serves on three public company boards.","Both directors are independent under NYSE rules; board now has 11 members (10 independent, 4 women)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":406772,"accession_number":"0001157523-21-001229","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2021-10-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q3 revenue $3,391M (+21.7% YoY), raises full-year 2021 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP diluted EPS $1.34 (up 157.7% YoY); adjusted diluted EPS $2.17 (up 33.1% YoY).","Adjusted EBITDA $728M (+20.5% YoY); operating cash flow $844M, free cash flow $682M.","R&D Solutions backlog $24.4B (+12.7% YoY); net book-to-bill 1.39x including pass-throughs.","FY2021 guidance raised: revenue $13,775-13,850M; Adj. EBITDA $2,980-3,010M; Adj. EPS $8.85-8.95.","Q4 2021 guidance: revenue $3,537-3,612M; Adj. EBITDA $786-816M; Adj. EPS $2.37-2.47."],"consensus_eps_estimate":null,"consensus_eps_actual":3.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":10238000000.0,"consensus_period":"2021-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":425780,"accession_number":"0001193125-21-256375","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2021-08-25T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"IQVIA refinances $2.7B credit facilities, extends maturity to 2026, reduces interest rates","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New Term A Dollar Loans of $1,451M and Term A Euro Loans of €317M refinanced; maturity extended from 2023 to 2026.","Revolving credit facilities: $675M U.S., $225M Japan, $600M Swiss/Multicurrency; also extended to 2026.","Interest rates on prior term A-2 loans reduced as part of refinancing.","U.S. Borrower added as borrower; existing letters of credit deemed issued under amended agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":425779,"accession_number":"0001157523-21-000922","cik":1478242,"company_name":"IQVIA HOLDINGS INC.","ticker":"IQV","form_type":"8-K","filed_at":"2021-07-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"IQVIA Q2 revenue $3,438M (+36.4% YoY); raises full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS $0.90 vs. $(0.12) YoY; adjusted diluted EPS $2.13, up 80.5%.","Adjusted EBITDA $722M (+49.5%); revenue beat on strong R&DS and TAS growth.","R&DS contracted backlog $23.9B, up 16.7%; net book-to-bill 1.34x for Q2.","FY2021 guidance raised: revenue $13.55-13.70B, Adj. EBITDA $2.95-3.00B, Adj. EPS $8.70-8.90.","Q2 free cash flow $394M; operating cash flow $539M; $822M remaining buyback auth."],"consensus_eps_estimate":null,"consensus_eps_actual":1.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":6847000000.0,"consensus_period":"2021-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":29871760026.70281,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2021-07-27T23:59:59+00:00|425779"}